Login
Discover
Waves
Communities
Write
Login
Signup
bscruggs
@bscruggs
30
Followers
273
Following
11
Follow
Email digest
Resource Credits
Available
Used
Created
2017-07-03 18:42
RSS Feed
Subscribe
Posts
Blog
Posts
Comments
Communities
Wallet
bscruggs
cryptocurrency
9y
Genesis Mining back to normal?!?!
I am starting to get payouts from Genesis Mining again. It looks like their issues may be resolved now.
$ 0.023
3
6
bscruggs
cryptocurrency
9y
Mysterium continues to rise
The price of Mysterium has increased to $1.50 with a 50% increase in the last 24 hours. The rank on coinmarketcap.com is 87. I was introduced to Mysterium by DataDash on YouTube in his video on top coins
$ 0.000
2
bscruggs
cryptocurrency
9y
Mysterium breaking out
Mysterium (MYST) is up more than 35% in the last 24 hours. Mysterium foundation is developing Mysterium Network – an Open source software, powering a Decentralized Network of VPN Nodes. The Mysterium Network
bscruggs
photography
9y
Insect of the day
Found this amazing creature on my back porch. Looks just like a leaf until you take a closer look!
bscruggs
vizsla
9y
Did someone say fetch?
Pick a toy, any toy!
bscruggs
dog
9y
Soaking up the sun
Catching some rays in the backyard. One happy vizsla.
bscruggs
photography
9y
An evening stroll with the deer
We went for a walk a dusk to avoid today's heat as much as possible. Great to get out of the house after spending much of the day inside. We were greeted by a few friends along the way. The deer were watching
bscruggs
photography
9y
Peaceful yard and sunset
Enjoying the evening sitting on the back porch listening to the crickets and frogs.
bscruggs
photography
9y
Sunset
Sunset
bscruggs
baseball
9y
Baltimore Orioles
Oriole Park at Camden Yards!
bscruggs
biotech
9y
Spark Therapeutics interim data
Spark Therapeutics (NASDAQ: ONCE) was up 9.21% in trading on Wednesday, July 5, 2017, closing at $65.56. $65 has been a resistance point in recent months. The company is scheduled to release interim data
bscruggs
biotech
9y
Who will Gilead acquire?
The buzz around a potential acquisition by Gilead continues. Last week a new name entered the ring - Vertex Pharmaceuticals. Leerink's Geoffrey Porges suggested this possibility. The scale of such an